Aging Code Summit

Aging Code Summit 2026

Join the world's leading scientists, investors, and entrepreneurs shaping the future of human healthspan

  • May 21, 2026
  • Zoom
  • ONLINE EVENT
  • LONGEVITY FOCUSED
  • NETWORKING ENABLED

Overview

Ahead of Aging Code Summit 2026, we will host a virtual pitch competition to identify the top
companies presenting live at the summit.

  • Two tracks: Seed and Series A
  • 10 companies per track, selected from applicants
  • Judges include accredited investors, pharma and hospital partners, and invited VIPs

The competition is designed to surface high-quality companies while creating meaningful
interaction between founders and decision-makers in the space.

Apply to pitch

Prizes

In partnership with The Engine

Grand Prize – Residency at The Engine

Awarded to 1 winning team per track

A transformative opportunity to embed within The Engine’s deep tech ecosystem, including up
to one year of Residency with access to lab space at significantly discounted rates. An ideal
launchpad to accelerate company growth and technical development.

Winners have 6 months to activate.

Runner-Up Prize – Flex Residency at The Engine

Awarded to 1 runner-up team per track

Up to one year of Flex Residency, providing access to The Engine’s network of founders,
investors, and operators. While this does not include lab space, it offers a strong foothold for
early-stage advancement.

Winners have 6 months to activate.

Questions? Contact us at agingcode@longevitygl.org

Apply to Sponsor Sustaining sponsor

Our Speakers

Our confirmed speakers for 2026

  • Kristen Fortney, PhD

    Kristen Fortney, PhD

    CEO & Co-Founder
    BioAge

  • Sharon Rosenzweig-Lipson, PhD

    Sharon Rosenzweig-Lipson, PhD

    CSO
    Life Biosciences

  • Fiona Miller

    Fiona Miller

    Managing Partner quadra
    Scope Ventures

  • Jamie Heywood

    Jamie Heywood

    CEO & Founder
    Alden Scientific

  • Manolis Kellis

    Manolis Kellis

    PhD, Professor of Computer Science & Computational Biology
    MIT

  • Mahdi Moqri

    Mahdi Moqri

    PhD Founding Co-Director
    Biomarkers of Aging Consortium

  • Christin Glorioso

    Christin Glorioso

    MD, PhD CEO & Founder
    NeuroAge Therapeutics

  • Saranya Wyles

    Saranya Wyles

    MD, PhD Medical Director
    Center for Aesthetic Medicine and Surgery Mayo Clinic

  • Doris Day

    Doris Day

    MD, FAAD, MA Physician, Clinical Professor, Director
    Day Dermatology and Aesthetics

  • Amy Proal

    Amy Proal

    PhD, CEO
    PolyBio Research Foundation

  • Ray Mak

    Ray Mak

    MD, Associate Professor
    Radiation Oncology Harvard Medical School

  • Justin Taylor

    Justin Taylor

    VP, Communications
    Boston Chapter Lead Longevity Global

  • Noriko Yokoi

    Noriko Yokoi

    PhD, Co-Founder
    3cubed.ai

  • Daniel Dacey

    Daniel Dacey

    PhD, Founder & CEO, Co-Founder
    Dovetail Biopartners, Mindvyne

  • Spring Behrouz

    Spring Behrouz

    PhD, CEO
    Vincere Biosciences

  • Raghav Sehgal

    Raghav Sehgal

    PhD
    Research Faculty Yale University

  • Li-Huei Tsai

    Li-Huei Tsai

    PhD, Professor & Director
    Picower Institute for Learning and Memory, MIT

  • José Navarro Betancourt

    José Navarro Betancourt

    MD, PhD, Scientific Director
    quadraScope Ventures

  • David Barzilai

    David Barzilai

    MD, PhD, MBA, MS, DipABLM
    Barzilai Longevity Consulting

  • Jay Luthar

    Jay Luthar

    MD, DipABLM, Founder
    Lutanen Health

  • Hillary Lin

    Hillary Lin

    MD, Co-Founder & CEO
    Care Core

  • Umbereen S. Nehal

    Umbereen S. Nehal

    MD, MPH, MBA, Founder
    HER Heard

  • Carla Pareja Paris

    Carla Pareja Paris

    JD, LLM, Associate
    Zuber Lawler

  • Robin Mansukhani

    Robin Mansukhani

    CEO
    Decidious Therapeutics

  • David Hall

    David Hall

    MHA, MA, MIS, PMP, VP
    Clinical Innovation RxPx

  • Yeh-Chuin Poh

    Yeh-Chuin Poh

    PhD SVP, Head of Tech Ops
    Tolerance Bio

  • Salah Mahmoudi

    Salah Mahmoudi

    PhD, CEO, Co-Founder
    ReneuBio Inc.

  • Ruta Laukien

    Ruta Laukien

    JD, LLM, MBA, Managing Partner
    GrayBella Capital

  • Jens Eckstein

    Jens Eckstein

    PhD, Investment Partner
    Hevolution Foundation

  • Anne-Ulrike Trendelenburg

    Anne-Ulrike Trendelenburg

    PhD, Executive Director
    DARe Cambridge lead Novartis BR

  • Yvanka de Soysa

    Yvanka de Soysa

    PhD, Associate
    Foreground Capital

  • Bradford Casey

    Bradford Casey

    PhD, Senior Associate Director of Research Programs
    The Michael J. Fox Foundation for Parkinson’s Research

  • Alan Alexander

    Alan Alexander

    MD, MSc, Co-Founder and CEO
    CoreViva

  • Andy Lee

    Andy Lee

    Co-Founder and CBO
    Vincere Biosciences

  • Nabiha Saklayen

    Nabiha Saklayen

    PhD, CEO & Co-Founder
    Cellino

  • Matt Lewis

    Matt Lewis

    MPA, CEO & Founder
    Transformental

  • Maha Elashri

    Maha Elashri

    CEO & Founder
    The Wellness Bureau

  • Suguna Rachakonda

    Suguna Rachakonda

    PhD, MBA, Vice President, Business Development
    Insilico Medicine

  • Geeta Vemuri

    Geeta Vemuri

    PhD, MBA, Founder & Managing Partner
    Agent Capital

  • Shane Hegarty

    Shane Hegarty

    PhD, CSO & Co-Founder
    Axonis Therapeutics

  • Daniel Carbonero

    Daniel Carbonero

    PhD, Investment Associate
    PsyMed Ventures

  • Ethan Than

    Ethan Than

    MBA, Global Digital/AI Partnerships & Transactions
    Sanofi

  • Rhie Lim

    Rhie Lim

    MBA, Partner, Global Strategy
    One Way Ventures

  • Stefanie Morgan

    Stefanie Morgan

    PhD, Vice President of Operations & Applied
    Science AgelessRx

  • Marianna Zaslavsky

    Marianna Zaslavsky

    MBA, Co-Director,
    Boston Chapter of Longevity Global

  • Brittany Ryan

    Brittany Ryan

    MBA, Founder & Principal
    Sunrise Advisors

  • Gabrielle Pavelko

    Gabrielle Pavelko

    DACM, Founder
    The Menopause Brain Trust

  • Luba Perry

    Luba Perry

    PhD, Co-Founder & CEO
    ReConstructBio

Selection Process

Scores and feedback are aggregated across all judges The top 3 companies from each track are selected Finalists will be: Announced at the end of Day 1 of Aging Code Summit Invited to pitch live on Day 2 after lunch All participating companies will receive anonymous feedback and rankings following the competition.

Breakout Sessions

Each round consists of: 15 minutes of live interaction ~5-minute pitch ~10-minute Q&A Followed by 5 minutes for scoring and feedback submission During each round: Judges are assigned to breakout rooms Each room includes at least 3 judges and 1 company All rooms run simultaneously with a shared timer At the end of each round, everyone is returned to the main room automatically Judges have 5 minutes to submit rankings and feedback before the next round begins This continues until all judges have evaluated every company in their assigned track.

Company Profiles & Visibility

All selected companies will be featured through FirstGlance, where structured company profiles will be created ahead of the competition. These profiles will be accessible to: Judges participating in the virtual competition Attendees of Aging Code Summit This ensures that companies are reviewed with context before pitching and allows for more informed discussions during both the virtual competition and the live event. Selected companies will be invited to join the Aging Code Summit 2026 group on FirstGlance, creating a centralized space for visibility and discovery. While profiles will be created for selected companies, setting up an account on FirstGlance in advance is encouraged and can be beneficial for broader exposure to investors and partners beyond the event.